Company intelligence / Profile preview
The Tetra Corporation
Torrance, California, United Statesthetetracorp.com ↗
- Ownership
- Private
- Employees
- ~22
- Development stage
- Other
01
Overview
The Tetra Corporation develops and markets physician-dispensed topical antifungal and skin care products. Its lead product, Formula 3® Antifungal, is FDA-approved for the treatment of fungal infections such as athlete’s foot and ringworm. Products are dispensed primarily through podiatric and dermatological practices. Clinical results are described as rapid and reliable with a focus on improving patient outcomes[1][2][3].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule (notably tolnaftate-based formulations)Topical formulationOTC medication (over-the-counter)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on The Tetra Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Tetra Corporation.